The design, synthesis and evaluation of hypoxia-activated pro-oligonucleotides

被引：23
|
作者：
Zhang, Nan [1 ,2 ]
Tan, Chunyan [1 ]
Cai, Puqin [1 ]
Zhang, Peizhuo [3 ]
Zhao, Yufen [2 ]
Jiang, Yuyang [1 ,4 ]
机构：
[1] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518055, Guangdong, Peoples R China
[2] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[3] Shanghai GenePharma Co Ltd, Shanghai 201203, Peoples R China
[4] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2009年 / 22期
关键词：
PRODRUGS;
D O I：
10.1039/b903331a
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hypoxia-activated pro-oligonucleotides were synthesized through the commercial phosphoramidite method, and could be readily cleaved to form normal oligos with good hypoxia selectivity in vitro under the effect of reductases, as well as in tumor cell extract.
引用
收藏
页码：3216 / 3218
页数：3
相关论文
共 50 条
  • [21] Optimised synthesis of a nitroCBI hypoxia-activated prodrug with substantial anticancer activity
    Lee, Ho H.
    Dickson, Benjamin D.
    Stevenson, Ralph J.
    Yang, Shangjin
    Tercel, Moana
    TETRAHEDRON, 2019, 75 (22) : 3001 - 3007
  • [22] A hypoxia-activated NO donor for the treatment of myocardial hypoxia injury
    Zhou, Wen
    Yang, Wanxiang
    Fan, Keyu
    Hua, Wuyang
    Gou, Shaohua
    CHEMICAL SCIENCE, 2022, 13 (12) : 3549 - 3555
  • [23] Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
    Li, Yue
    Zhao, Long
    Li, Xiao-Feng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Hypoxia-Activated Prodrugs of PERK Inhibitors
    Liew, Lydia P.
    Singleton, Dean C.
    Wong, Way W.
    Cheng, Gary J.
    Jamieson, Stephen M. F.
    Hay, Michael P.
    CHEMISTRY-AN ASIAN JOURNAL, 2019, 14 (08) : 1238 - 1248
  • [25] Evaluation of heteroaxial cobalt(III) complexes as archetypes for hypoxia-activated prodrugs
    Batista, Renata Crispim
    Gomez, Javier Gomez
    Verani, Claudio Nazari
    Lanznaster, Mauricio
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2017, 22 : S61 - S61
  • [26] Targeting tumors with hypoxia-activated cytotoxins
    Ahn, G-One
    Brown, Martin
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 3483 - 3501
  • [27] Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy
    Brender, Jeffrey R.
    Saida, Yu
    Devasahayam, Nallathamby
    Krishna, Murali C.
    Kishimoto, Shun
    ANTIOXIDANTS & REDOX SIGNALING, 2022, 36 (1-3) : 144 - 159
  • [28] Anticancer efficacy of the hypoxia-activated pro-drug evofosfamide in prcelinIcal osteosarcoma murine models
    Liapis, Vasilios
    Labrinidis, Agatha
    Zinonos, Irene
    Hay, Shelley
    Ponomarev, Vladimir
    Panagopoulos, Vasilios
    DeNichilo, Mark
    Ingman, Wendy
    Atkins, Gerald J.
    Findlay, David M.
    Evdokiou, Andreas
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S59 - S59
  • [29] Hypoxia-activated prodrugs forge ahead in cancer
    Jim Kling
    Nature Biotechnology, 2012, 30 : 381 - 381
  • [30] Hypoxia-activated nanomedicines for effective cancer therapy
    Zhou, Mengjiao
    Xie, Yuqi
    Xu, Shujun
    Xin, Jingqi
    Wang, Jin
    Han, Tao
    Ting, Richard
    Zhang, Jie
    An, Feifei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 195
12345